by Raynovich Rod | Aug 19, 2019 | Biopharmaceuticals, Clinical Diagnostics and Tools, Macro
Bearish Trends in BiopharmaEmerge in 2019 Need Drivers for Q4 rally like M&A, clinical breakthroughs and respite from macro and trade news. Time to rebalance life science portfolios with services, tools and diagnostics. Biopharma Stocks topped out in April 2019...
by Raynovich Rod | Aug 12, 2019 | Biopharmaceuticals, Clinical Diagnostics and Tools, Macro
Update-3…8/16 Big reversal day…summary this weekend with XBI up 2.65% at $82.46 just above support. Update-2… 8/14 Nowhere to hide from Global economic fears-welcome to whipsaw trading. Technicals matter not tweets. Market averages down about 3%...
by Raynovich Rod | Jul 28, 2019 | Biopharmaceuticals
8/5… Risk OFF with Trade War and a Currency War XBI down 3.33% to $81.22, IBB down 2.65% to $102.29. WE will update later this week. Tuesday 8/6 we will attend the AACC Clinical EXPO in Anaheim CA. ======== Update-2..8/1 1:30p VRTX sparks biopharma stocks up 6%...
by Raynovich Rod | Jul 22, 2019 | Biopharmaceuticals, Macro
Update -3 …Nice biotech rally today; green screen in gene therapy and mid-cap sectors. XBI and IWM up over 1%. Update-2…Small cap reversal IWM up 1.67% to $157 level; our small cap portfolio winners: AMRN CFMS GNMK MGTX VCEL etc. but XBI still lags stuck...
by Raynovich Rod | Jul 15, 2019 | Biopharmaceuticals, Macro
Update-2 11:30a EDT Seattle Genetics (SGEN) revenues grow 30% , stock soars 15%.This is the way large cap biotech model is supposed to work-grow top line revenue.The Company is a leader in oncology with antibody-drug conjugates (ADC). ===== Update-1 Biopharma stocks...
by Raynovich Rod | Jul 11, 2019 | Biopharmaceuticals
Update-1 11a EDT, Large cap drugs and biotechs resume slide on drug pricing “reform” from Trump threats. IBB down 1.37%, XPH in downtrend tp $38.41. Laggards holding BIB, GILD. Winners losing MRK, RHHBY. LLY and PFE hit hard. Gene therapy green: BOLD,SGMO....
by Raynovich Rod | Jun 30, 2019 | Biopharmaceuticals
Update-1 A bit of a sell-off in gene therapy but MGTX at new highs at $29.44. Profit taking on Sarepta down 3.84% to $150.59. Roche (RHHBY) and Merck (MRK) near new highs. Mid-caps mixed but Novacure (NVCR) rally 3.27% toward new highs. One of our top picks Amarin...
by Raynovich Rod | Jun 27, 2019 | Biopharmaceuticals, Macro
Crazy Stealth Biotech Rally in Small Caps-Who Gave the Buy Signal? NASDAQ up 0.73%, XLV up 0.70 %. MedTech and Dx/Tools also green. IWM up 1.88% to $153.63 up 14% YTD, lagging XBI up 20.7% YTD. Volatile market for traders in small caps. It was a green screen for small...
by Raynovich Rod | Jun 24, 2019 | Biopharmaceuticals, Macro
Update-2… 6/27 2p EDT…Good day for gene therapy stocks My longs CRSP and MGTX are up. Looking better all across the screen in biopharma. Added to ABBV and XNCR yesterday. XBI up but still under $86. Update-1… Another Big Deal in Biotech in a weak...
by Raynovich Rod | Jun 17, 2019 | Biopharmaceuticals
Update-3. Red screen day, post after close, macro intervening again. BMY/CELG delayed on Otezla divestiture. Update -2 …Week Ending 6/21-Biotech stocks up for the week but momentum easing. XBI up 1.2% to $87.26, off Wednesday highs. IBB up .2.2% to $109.45 QQQ...
